Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-889P is a processed pseudogene related to the U6 small nuclear RNA gene family, which encodes a non-coding RNA component of the spliceosome in its functional form. Pseudogenes such as RNU6-889P arise through gene duplication or retrotransposition and normally do not generate functional RNA or protein products. Most U6 pseudogenes, including RNU6-889P, are non-functional genomic elements without known physiological or pathological significance, although in rare cases, pseudogene transcripts can have regulatory effects (for instance, by acting as microRNA decoys or producing small interfering RNAs). RNU6-889P itself is not a principal focus of biomedical research, is not considered a therapeutic target, and is largely of interest for reference in genomics and bioinformatics databases.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 889, pseudogene (RNU6-889P).